The effect of ARBs and ACEIs on SARS-CoV-2: Exploring the controversy

Abstract

As the COVID-19 pandemic spread quickly across the world, one of the largest emerging debates in the science community was surrounding the risk of COVID-19 (also referred to as SARS-CoV-2) as an effect of the regular use of anti-hypertensive medications. In this article, this debate and the controversy that followed will be analyzed by outlining the elements of the biological system involved, then analyzing its importance, the implicated arguments, and the controversy itself.